Dupixent 300 MG/2 ML pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26FM6A1
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $68,349
Award facts
- Contract value 100% obligated
- $68,348.52 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $68,348.52 to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 ml pen injectors on December 8, 2025, with completion expected by December 9, 2025. This competitively awarded, firm fixed-price delivery order represents a continuation of critical pharmaceutical supply support to federal medical systems. The contract will be fulfilled from AmerisourceBergen's Conshohocken, Pennsylvania location, serving as a child order under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical.
This delivery order falls under AmerisourceBergen Drug Corp's existing $999,999,999.00 indefinite delivery vehicle (SPE2DX) with the Defense Logistics Agency, which extends through December 2026 and authorizes the distributor to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen maintains an extensive portfolio of federal contract awards covering diabetes medications, neurological treatments, pain management pharmaceuticals, antibiotics, and specialized medical supplies. The Dupixent supply supports the Defense Health Agency and other government healthcare systems requiring biologic immunosuppressant therapy for conditions such as atopic dermatitis and asthma.
Quick answers
Who was awarded contract SPE2DR26FM6A1?
SPE2DR26FM6A1 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 8, 2025.
How much is contract SPE2DR26FM6A1 worth?
The government has obligated $68,349 on SPE2DR26FM6A1.
Is contract SPE2DR26FM6A1 an order under another contract?
Yes. SPE2DR26FM6A1 is a delivery order under SPE2DR25D2211, an indefinite delivery contract.
Was contract SPE2DR26FM6A1 competed?
The extent of competition for SPE2DR26FM6A1 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award